Meenu Ghai

Meenu Ghai

Auto-generated profile, based on publicly available information

Meenu Ghai

School of Life Sciences, University of KwaZulu-Natal, Private Bag X54001, Westville, Durban 4000, South Africa

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2016 in Molecular Genetics and Genomics
Verified
Journal Article
Closed access
PDF file
FKFarzeen Kader
Farzeen Kader
MGMeenu Ghai
Meenu Ghai

1 April 2015 in Forensic Science International
Verified
Journal Article
Closed access
FKFarzeen Kader
Farzeen Kader
MGMeenu Ghai
Meenu Ghai

12 November 2019 in International journal of legal medicine
Verified
Journal Article
Closed access
FKFarzeen Kader
Farzeen Kader
MGMeenu Ghai
Meenu Ghai
AOAdemola Olaniran
Ademola Olaniran

6 September 2024 in Gene
Verified
Journal Article
Open access
PGPriyanka Govender
Priyanka Govender
MGMeenu Ghai
Meenu Ghai
Differences in microbial communities at different body habitats define the microbiome composition of the human body. The gut, oral, skin vaginal fluid and tissue microbiome, are pivotal for human development and immune response and cross talk between these microbiomes is evident. Population studies reveal that various factors, such as host genetics, diet, lifestyle, aging, and geographical location are strongly associated with population-specific microbiome differences. The present review discusses the factors that shape microbiome diversity in humans, and microbiome differences in African, Asian and Caucasian populations. Gut microbiome studies show that microbial species Bacteroides is commonly found in individuals living in Western countries (Caucasian populations), while Prevotella is prevalent in non-Western countries (African and Asian populations). This association is mainly due to the high carbohydrate, high fat diet in western countries in contrast to high fibre, low fat diets in African/ Asian regions. Majority of the microbiome studies focus on the bacteriome component; however, interesting findings reveal that increased bacteriophage richness, which makes up the virome component, correlates with decreased bacterial diversity, and causes microbiome dysbiosis. An increase of Caudovirales (bacteriophages) is associated with a decrease in enteric bacteria in inflammatory bowel diseases. Future microbiome studies should evaluate the interrelation between bacteriome and virome to fully understand their significance in the pathogenesis and progression of human diseases. With ethnic health disparities becoming increasingly apparent, studies need to emphasize on the association of population-specific microbiome differences and human diseases, to develop microbiome-based therapeutics. Additionally, targeted phage therapy is emerging as an attractive alternative to antibiotics for bacterial infections. With rapid rise in microbiome research, focus should be on standardizing protocols, advanced bioinformatics tools, and reducing sequencing platform related biases. Ultimately, integration of multi-omics data (genomics, transcriptomics, proteomics and metabolomics) will lead to precision models for personalized microbiome therapeutics advancement.

1 July 2018 in Behavioural Brain Research
Verified
Journal Article
Closed access
FKFarzeen Kader
Farzeen Kader
MGMeenu Ghai
Meenu Ghai
LMLeah Maharaj
Leah Maharaj

8 October 2018 in Scandinavian Journal of Immunology
Verified
Journal Article
Open access
PDF file
VNVelosha Naidoo
Velosha Naidoo
MNMerusha Naidoo
Merusha Naidoo
MGMeenu Ghai
Meenu Ghai
Type 2 diabetes mellitus (T2 DM ) is a chronic metabolic disorder characterized by hyperglycaemia, which can cause micro‐ and macrovascular complications. Chronic inflammation may be the cause and result of T2 DM , and its related complications as an imbalance between pro‐ and anti‐inflammatory cytokines can affect immune functions. Apart from genetic changes occurring within the body resulting in inflammation in T2 DM , epigenetic modifications can modify gene expression in response to environmental cues such as an unhealthy diet, lack of exercise and obesity. The most widely studied epigenetic modification, DNA methylation ( DNA m), regulates gene expression and may manipulate inflammatory genes to increase or decrease inflammation associated with T2 DM . This review explores the studies related to epigenetic changes, more specifically DNA m, associated with chronic inflammation in T2 DM , at both the cell and tissue levels. Studying epigenetic alterations during inflammatory response, as a result of genetic and environmental signals, creates opportunities for the development of “early detection/relative risk” tests to aid in prevention of T2 DM . Understanding inflammation in T2 DM at the gene level in inflammation‐associated cells and tissues may provide further insight for the development of specific therapeutic targets for the disorder.